QUT PhD candidate Clarence Baxter has developed a browser-based smartphone app to deliver therapy for people recovering from surgery and those with lung conditions involving overproduction of mucus.
The QUT Inspire ISy app has been tested and compared with a Triflo II clinical incentive spirometry device by 24 healthy participants with the study’s results published in the BMJ Open Respiratory Research journal.
It is a web app using the built-in microphone available in all smartphones to detect inspiratory sounds, which offers a responsive animated graphic display for as long as detectable breath sound is sustained.
Clarence Baxter said the app, a ‘virtual’ form of a longstanding clinical incentive spirometer (ISy) used to detect a person’s inspiratory breath, is intended to encourage persistence with repeated gradual maximal inspirations for respiratory therapy.
“The app was developed as a low-cost, easy-to-use way to promote repeated deep inhalations by patients to dislodge mucus from the airways so that it can be expelled by coughing,” Baxter said.
“Removing mucus from the lungs is important when recovering after surgery as it may collect in the tiny air sacs or alveoli of the lungs while a patient is prone for a long time, presenting risks of developing respiratory infections or pneumonia.
“The traditional clinical ISy device has a tube from which users inhale in order to create a vacuum to raise three spheres in separate clear chambers. The aim is to keep the three spheres aloft using a sustained slow deep inhalation to encourage dislodgement of mucus from the airways.
“Obviously the user can see how they are doing by watching the spheres rise in the clinical ISy device, and so we used this visualisation virtually in the app to give users the same visual cues regarding their inhalations.”
In the first phase of this new clinical study, participants compared three gradual maximal inhalations using the QUT ISy app with three inhalations using the clinical ISy device.
“We randomly assigned the testing order so that some participants used the app first and the ISy second and vice versa to avoid any device testing order effects.
“Usability was measured for three factors: effectiveness — the duration of sustained inhalation effort; efficiency — assessed by using the distance participants held their phones from their mouths; and, user satisfaction assessed by a post-test questionnaire and qualitatively through semi-structured interviews.
“No significant difference was found between the duration of inhalations (in seconds) using the QUT ISy app compared with the Triflo II clinical ISy device.
While participants were asked to hold the phone less than 5 cm from their mouths to capture the inhalation sound, most held their phones on average about 13 cm away, possibly to better view the screen, Baxter said.
“Even so, this distance was within the detection range of approximately 50 cm for medium and high inhalation flow sounds identified in an earlier simulation study using this app,” he said.
“User satisfaction was high with most participants preferring the new virtual app as best for displaying inspirations. They reported the app’s screen display had the advantage of responsiveness and compactness over the Triflo II.”
People with cystic fibrosis have an ongoing overproduction of mucus (including mucus in the airways) and could benefit from using the app as they would need no other equipment other than their smartphone, according to Baxter.
“Other potential users include people with chronic obstructive pulmonary disease who may have reduced lung elasticity or other pathological lung changes resulting in accumulation of mucus.
“As this study shows healthy participants reported the app encouraged inhalations of comparable vigour and duration with the traditional IS device, further studies with more vulnerable groups with these relevant disease conditions are warranted.”
NSW Health, with support from ACON, will commence a targeted vaccination program against...
A recent review of PCOS research and care provides a summary of best-practice evidence and...
Hollywood Private Hospital is set to become a training and education hub for Hybrid Catheter...
Improve Outcomes with the HIMSS EMR Adoption Model and the Right Solutions
How technology can improve the patient healthcare experience
Medical facilities lift their healthcare game with LINAK innovations
Innovative enclosed blood collection system
Your sustainable solution to the disposable crisis
Healthy data starts with InterSystems
Ovid Synthesis® — Clinical Evidence Manager
Lippincott Procedures: Point of Care Resources
Climate Bill passes lower house
Victorian circular plastics facilities engage Aerofloat for wastewater treatment
Creating meaningful impact and building consumer trust through action and innovation
What does ESG and urban growth mean for waste operators?
Westfield switches to 100% renewable energy in Qld
FSANZ accepting comments regarding processing aid
New Zealand Winegrowers' 2022 Fellows announced
The Fresh Produce Safety Conference approaches
APPMA partners with Modern Manufacturing Expo
Using stickers and a smartphone to detect nitrite
Synthetic embryo models created solely from stem cells
Cryogenic blast freezing to -90°C in minutes increases throughput
Aus secures monkeypox vaccines, NSW rollout begins
Peptide 'fingerprint' enables earlier Alzheimer's diagnosis
'Y' are men at higher risk of heart failure?
Westwick-Farrow Media Locked Bag 2226 North Ryde BC NSW 1670 ABN: 22 152 305 336 www.wfmedia.com.au Email Us
Hospital + Healthcare provides busy hospital, health and aged care professionals with an easy-to-use, readily available source of information, crucial to gaining valuable industry insight. Members have access to thousands of informative items across a range of media channels.
Membership is FREE to qualified industry professionals across Australia.